“We need to be having more conversations about menopause”
Women and Parkinson's
Author: Heather KennedyPublished: 28 November 2019
Prep: Cook: Serves:
Heather Kennedy, a writer, advocate and mother who
lives near San Francisco, US, lays bare the physical and emotional challenges
of managing the onset of menopause with Parkinson’s – from the night sweats and
a decreasing interest in sex to the sense of “turning inwards”
I was first diagnosed with Parkinson’s in 2011, at the age
As I approach the menopause, I’ve noticed changes in
myself. First of all, I have a lower libido. I just want nothing to do with sex
at the moment, which is unusual! Secondly, I find myself turning inwards. I
find myself getting quieter and retreating into my shell, which means I’m
further isolating myself inside this condition. I implore women with
Parkinson’s to make sure you connect with other women at this time in your life
– talk to one another, come together. We need to be having way more
conversations about menopause, and particularly about how menopause affects
women with Parkinson’s. This getting smaller, this sense of receding as a
person – it’s the opposite of what people with Parkinson’s should be doing.
I never questioned how the condition might affect me as a woman until I started experiencing unexplainable off times in the days leading up to my periods. I was complaining to my girlfriends, when one friend schooled me. She explained that during periods the efficacy of women’s medication decreases. No one had ever told me that! I then started to notice the pattern like clockwork. Since being perimenopausal, though, my periods have become far more unpredictable in heaviness and length.
“That just doesn’t
I have started to sweat through my sheets every night. I
was unsure if it was a result of my medication or because of the menopause, and
that’s the problem – none of these changes happen inside a vacuum. It’s not like
I can pinpoint that ‘this thing is caused by hormonal changes’ and ‘this part
is caused by medication’. All of these things melt into one so it’s hard to
tell what’s happening to my body. Most of the time the doctors can’t tell.
I tried to ask my doctor if the night sweats could be
because of the menopause. He insisted I was too young – even though at 49 I
don’t think I am – and just told me to see my gynaecologist. Though he is
usually patient, I was a little surprised at how he brushed me off.
There are other ways my progressing Parkinson’s affects me as a woman, urinary incontinence being one. Sometimes I’m too stubborn to wear a pad – I’d rather pee in my pants than wear a big honking mattress between my legs! That just doesn’t feel sexy! I suppose getting old in itself makes you feel a little less juicy but combine that with the symptoms associated with this condition – and the onset of menopause – and it’s fair to say I feel a little more insecure these days. Dating men has made that harder too. As soon as I say I have Parkinson’s, I never hear from them again.
One thing I’ve noticed in the Parkinson’s community is how women are openly shamed for experiencing impulse control disorders to do with sex (hyper compulsion being a side effect from our Parkinson’s medication) but when it’s men you hear that phrase: ‘Boys will be boys’. I just think that dynamic is so wrong. I experienced hyper compulsion but in my case it was with cleaning and shopping. I got very intense about cleaning out the closet – my daughter said, ‘Mum, you’ve been cleaning the closet for three days’. These drugs are powerful, and they cause major changes in us. We need more warning about that.
Need to know: Heather Kennedy– whose pen name is Kathleen Kiddo – is a writer, speaker and Parkinson’s advocate who was diagnosed with Parkinson’s in 2011 at the age of 41. She lives with her two children in California, US. Heather is publishing two new books, one on grief and the other a collection of short stories, in the coming year.
Parkinson’s and menopause: the facts
Common side-effects of menopause can often be confused with Parkinson’s symptoms
Currently there isn’t enough research on women with Parkinson’s for doctors to know whether to recommend the use of hormone replacement therapy (HRT)
A study involving a group of women with Parkinson’s aged 35 to 59 revealed that many were anxious about their bodies and sexual image – unfortunately such concerns are rarely addressed by doctors
It is estimated that three million women worldwide are living with Parkinson’s – yet their specific needs and experiences are often ignored, leading to disparities in diagnosis, treatment and medication. Each week, we’ll be sharing the little-heard stories of women with the condition to find out how their lives are being affected by a shocking data gap when it comes to women and Parkinson’s. This is just the start.
We want to raise awareness of women’s experience of the condition within the medical profession, so that women’s symptoms are taken seriously.
We think more research is needed into the impact of Parkinson’s on women, so that they can benefit from tailored medication and treatment.
We want to explore ways to offer better support for those women managing the condition alongside caring responsibilities.
Join us – #WomenAndParkinsons.
For more information on women and Parkinson’s please visit the EPDA website.
If you have a story to tell about being a woman with Parkinson’s – or some information about the impact of the condition on women for us to share with the global Parkinson’s community – please get in touch.
Michael J Fox records special message for “inspirational” Parkinson’s athlete
The ‘Back to the Future’ actor recorded a message for a TV show contest
6 hours ago
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”